Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Long-Term Debt Issuances (2013 - 2024)

Updated

Skye Bioscience's Long-Term Debt Issuances was $450,000 in FY2020, down 88.7% from $3.99 million in FY2019.

Analysis

Skye Bioscience (SKYE) Long-Term Debt Issuances (2013 - 2024) Analysis & Trends

From FY2012 onward, Skye Bioscience has reported Long-Term Debt Issuances for 6 years.

  • Long-Term Debt Issuances shows a three-year compound annual growth rate of -3.5% (FY2017 to FY2020).
  • Annual Long-Term Debt Issuances has moved between $400,000 (FY2018) and $3.99 million (FY2019) over five years.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $3.99 million in FY2019 (+897.7%), $400,000 in FY2018 (-20.0%) and $500,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.98 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Skye Bioscience 5.38 Mn -52.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 83.56 Mn
Dec 31, 2023 6.76 Mn
Mar 31, 2018 400,000.00
Jan 31, 2013 32,000.00
API Access

Skye Bioscience Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SKYE&period=max&api_key=YOUR_API_KEY